Universal Cells Analysis: $300K Raised
What is Universal Cells?
Universal donor stem cells via rAAV gene editing
Location
Seattle, United States
Employees
51-200
Founded
2013
Product Features & Capabilities
- Engineered universal donor pluripotent stem cells
- rAAV-based gene editing for immune recognition
- Off-the-shelf therapeutic cell production
Use Cases
Engineer stem cells for immune compatibility in clinical trials; Edit HLA genes to create universal donor cells; Produce differentiated therapeutic cells for regenerative medicine; Enable off-the-shelf cell therapy for autoimmune diseases; Support allogeneic cell therapy development in Type 1 diabetes and spinal cord injury
Other Considerations
Anastellas Company; Founded in 2013; 11-50 employees; Seattle, WA HQ; Technology based on UW intellectual property; Uses nuclease-free rAAV vectors for gene editing
